These data show that FAK-MMP9 signaling is promoted by activated HSCS and plays a role in modulating metastasis of HCC following activation of HSCs; thus, highlighting the crosstalk between tumor cells and activated HSCs in the hepatic TME. This evidence concerns the gene MMP9 and hepatocellular carcinoma.